Dube Michael P — SEC Form 4 filings

SEC reporting owner CIK 2019493. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-07-03 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intellia Therapeutics, Inc. (NTLA)VP, Chief Accounting Officer85 legs · 12,016 sh · $167,5163

Form 4 filings — Dube Michael P

FiledFormIssuerReported transactionsSource
2026-07-064Intellia Therapeutics, Inc. (NTLA)Sale (S): 2,641 @ $16.78EDGAR
2026-03-034Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 17,250 @ $0EDGAR
2026-01-074Intellia Therapeutics, Inc. (NTLA)Sale (S): 2,989 @ $9.21EDGAR
2025-10-034Intellia Therapeutics, Inc. (NTLA)Sale (S): 1,871 @ $17.38EDGAR
2025-07-034Intellia Therapeutics, Inc. (NTLA)Sale (S): 2,503 @ $9.95EDGAR
2025-03-044Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 14,000 @ $0EDGAR
2024-10-044Intellia Therapeutics, Inc. (NTLA)Sale (S): 2,012 @ $19.01EDGAR
2024-07-034Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 17,801 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2019493 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →